RxDoctor Payments Data

Jennifer Connell

Family · Grand Blanc, MINPI 1578881827

Payments from drug & device makers

$4,272in general payments, 2019–2025

Across 222 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$964
  • Merck$902
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$287
  • Kestra Medical Technology Services, Inc.$230
  • Boston Scientific$230
  • Boehringer Ingelheim$200
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$4,17298%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,272 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban115$125,052
EntrestoSacubitril/Valsartan44$59,672
Repatha SureclickEvolocumab36$41,545
MultaqDronedarone Hcl31$35,387
XareltoRivaroxaban41$33,975
BrilintaTicagrelor24$23,865
Ranolazine ErRanolazine13$1,644
ClopidogrelClopidogrel Bisulfate70$1,351
Isosorbide Mononitrate ErIsosorbide Mononitrate50$1,068
Rosuvastatin Calcium48$970
Carvedilol66$923
Atorvastatin Calcium71$886
Metoprolol Succinate51$883
Metoprolol Tartrate108$761
Amlodipine Besylate73$744

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$130$125,052115 claims
NovartisEntresto$964$59,67244 claims
Sanofi-aventis U.S. LLCMultaq$63$35,38731 claims
Johnson & JohnsonXarelto$113$33,97541 claims
AstraZenecaBrilinta$179$23,86524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.

Other family in Grand Blanc

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →